Resources: Page 265

Is WBUS necessary for women undergoing tomosynthesis?
By Kate Madden Yee
Wednesday, November 30 | 11:50 a.m.-12:00 p.m. | SSK02-09 | Room E451AIn this Wednesday session, researchers from Memorial Sloan Kettering Cancer Center will share research that indicates the clinical value of whole-breast ultrasound (WBUS) is reduced in women undergoing digital breast tomosynthesis rather than regular digital mammography.
November 1, 2016
Breast cancers found only on US have positive outcomes
By Kate Madden Yee
Wednesday, November 30 | 11:40 a.m.-11:50 a.m. | SSK02-08 | Room E451ADo breast cancers found only on ultrasound have positive outcomes? Yes, according to this study from South Korea.
November 1, 2016
CAD improves radiologists' ABUS reads
By Kate Madden Yee
Wednesday, November 30 | 11:10 a.m.-11:20 a.m. | SSK02-05 | Room E451AUsing computer-aided detection (CAD) software with automated breast ultrasound (ABUS) improves radiologists' interpretation performance, both in accuracy and reading time, according to researchers from China.
November 1, 2016
CAD improves ABUS efficiency in women with dense tissue
By Kate Madden Yee
Wednesday, November 30 | 11:00 a.m.-11:10 a.m. | SSK02-04 | Room E451AEuropean researchers have found that dedicated computer-aided detection (CAD) software for automated breast ultrasound (ABUS) improves the efficiency of the modality when used for supplemental imaging in women with dense breast tissue.
November 1, 2016
BI-RADS 3 breast lesions safe to track with 12-month US
By Kate Madden Yee
Wednesday, November 30 | 10:50 a.m.-11:00 a.m. | SSK02-03 | Room E451ASupplemental ultrasound for women with dense breasts finds cancers mammography doesn't, but it can also lead to many follow-ups at short-term intervals, especially if lesions are categorized as BI-RADS 3. Could these lesions be tracked at a longer interval?
November 1, 2016
Does including the axilla help or hinder breast US?
By Kate Madden Yee
Wednesday, November 30 | 10:40 a.m.-10:50 a.m. | SSK02-02 | Room E451AShould the axilla be included in supplemental screening breast ultrasound? Probably not, according to South Korean researchers.
November 1, 2016
CEUS biopsy shows promise for breast cancer staging
By Kate Madden Yee
Tuesday, November 29 | 3:50 p.m.-4:00 p.m. | SSJ02-06 | Room E450AMicrobubble contrast-enhanced ultrasound (CEUS) fine-needle aspiration biopsy is a viable, less invasive way to evaluate sentinel lymph nodes in breast cancer patients compared with surgical lymph node staging, according to a new study.
November 1, 2016
Can telerobotic US effectively perform abdominal exams?
By Kate Madden Yee
Tuesday, November 29 | 3:40 p.m.-3:50 p.m. | SSJ08-05 | Room E353ACan a telerobotic ultrasound system effectively perform abdominal ultrasound exams -- and therefore expand patients' access to care? Yes, according to research being discussed on Tuesday.
November 1, 2016
Contrast mammo more sensitive than WBUS for breast screening
By Kate Madden Yee
Tuesday, November 29 | 3:40 p.m.-3:50 p.m. | SSJ01-05 | Arie Crown TheaterIn this Tuesday session, researchers from Memorial Sloan Kettering Cancer Center will present study data that show contrast-enhanced digital mammography to be more sensitive than whole-breast screening ultrasound (WBUS) for supplemental breast cancer screening.
November 1, 2016
Could US tomography replace MRI for breast imaging?
By Kate Madden Yee
Tuesday, November 29 | 3:20 p.m.-3:30 p.m. | SSJ02-03 | Room E450ACould ultrasound tomography replace -- or at least offer an alternative to -- breast MRI? Perhaps, according to researchers from Delphinus Medical Technologies.
November 1, 2016
CEUS matches CT, MRI for evaluating liver masses
By Kate Madden Yee
Tuesday, November 29 | 3:10 p.m.-3:20 p.m. | SSJ08-02 | Room E353ACanadian researchers have found that contrast-enhanced ultrasound (CEUS) performs better than grayscale ultrasound for evaluating focal liver masses -- and its performance is at least equivalent to CT and MRI.
November 1, 2016
Subharmonic US helps predict breast cancer chemo response
By Kate Madden Yee
Tuesday, November 29 | 3:00 p.m.-3:10 p.m. | SSJ21-01 | Room S403AContrast-enhanced subharmonic imaging and 4D subharmonic-aided pressure estimation may help clinicians predict the chemotherapy treatment response of breast cancers before tumor size changes can be seen, according to researchers from Thomas Jefferson University.
November 1, 2016
Previous Page
Page 265 of 725
Next Page